A single domain antibody against the Cys- and His-rich domain of PCSK9 and evolocumab exhibit different inhibition mechanisms in humanized PCSK9 mice
暂无分享,去创建一个
A. Prat | N. Seidah | A. Chamberland | R. Essalmani | Delia Susan-Resiga | J. Marcinkiewicz | Anna Roubtsova | Elodie Weider